{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T09:14:41Z","timestamp":1774430081197,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,7,11]],"date-time":"2014-07-11T00:00:00Z","timestamp":1405036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.seizure.2014.06.001","type":"journal-article","created":{"date-parts":[[2014,6,8]],"date-time":"2014-06-08T04:46:19Z","timestamp":1402202779000},"page":"732-739","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Pharmacodynamic and pharmacokinetic interactions of perampanel and other antiepileptic drugs in a rat amygdala kindling model"],"prefix":"10.1016","volume":"23","author":[{"given":"Ting","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Nagaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahisa","family":"Hanada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.seizure.2014.06.001_bib0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1528-1167.2007.00992.x","article-title":"Refractory epilepsy: clinical overview","volume":"48","author":"French","year":"2007","journal-title":"Epilepsia"},{"issue":"Suppl. 8","key":"10.1016\/j.seizure.2014.06.001_bib0010","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1528-1167.2009.02238.x","article-title":"Rational polytherapy","volume":"50","author":"French","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2014.06.001_bib0015","series-title":"Fycompa summary of product characteristics","author":"European Medicines Agency","year":"2012"},{"key":"10.1016\/j.seizure.2014.06.001_bib0020","series-title":"Fycompa prescribing information","author":"Food and Drug Administration","year":"2012"},{"key":"10.1016\/j.seizure.2014.06.001_bib0025","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1212\/WNL.0b013e3182635735","article-title":"Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304","volume":"79","author":"French","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2014.06.001_bib0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1528-1167.2012.03638.x","article-title":"Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305","volume":"54","author":"French","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2014.06.001_bib0035","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1212\/WNL.0b013e318254473a","article-title":"Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures","volume":"78","author":"Krauss","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2014.06.001_bib0040","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1111\/epi.12240","article-title":"Concentration-effect relationships with perampanel in patients with pharmacoresistant partial-onset seizures","volume":"54","author":"Gidal","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2014.06.001_bib0045","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1528-1167.2011.03109.x","article-title":"Perampanel: a novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy","volume":"52","author":"Hanada","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2014.06.001_bib0050","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nrneurol.2012.222","article-title":"Epilepsy: perampanel-new promise for refractory epilepsy?","volume":"8","author":"L\u00f6scher","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.seizure.2014.06.001_bib0055","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1111\/epi.12212","article-title":"Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: a pooled analysis of three phase III studies","volume":"54","author":"Steinhoff","year":"2013","journal-title":"Epilepsia"},{"issue":"Suppl. 3","key":"10.1016\/j.seizure.2014.06.001_bib0060","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.yebeh.2005.08.005","article-title":"Models of epilepsy in the developing and adult brain: implications for neuroprotection","volume":"7","author":"Stafstrom","year":"2005","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2014.06.001_bib0065","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0014-4886(86)90160-3","article-title":"Is amygdala kindling in rats a model for drug-resistant partial epilepsy?","volume":"93","author":"Loscher","year":"1986","journal-title":"Exp Neurol"},{"key":"10.1016\/j.seizure.2014.06.001_bib0070","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1528-1167.2006.00952.x","article-title":"Synergistic combinations of anticonvulsant agents: what is the evidence from animal experiments?","volume":"48","author":"Jonker","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2014.06.001_bib0075","series-title":"Ionotropic glutamate receptors as therapeutic targets","first-page":"91","article-title":"Epilepsy","author":"L\u00f6scher","year":"2002"},{"key":"10.1016\/j.seizure.2014.06.001_bib0080","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.seizure.2014.06.001_bib0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0014-2999(97)01347-2","article-title":"BW1003C87, phenytoin and carbamazepine elevate seizure threshold in the rat amygdala-kindling model of epilepsy","volume":"339","author":"Morimoto","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.seizure.2014.06.001_bib0090","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","article-title":"Modification of seizure activity by electrical stimulation. II. Motor seizure","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/j.seizure.2014.06.001_bib0095","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/epi.12043","article-title":"Extended-release antiepileptic drugs: a comparison of pharmacokinetic parameters relative to original immediate-release formulations","volume":"54","author":"Leppik","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2014.06.001_bib0100","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/0028-3908(90)90159-O","article-title":"Phenytoin potently increases the threshold for focal seizures in amygdala-kindled rats","volume":"29","author":"Rundfeldt","year":"1990","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.seizure.2014.06.001_bib0105","first-page":"167","article-title":"Impact of concomitant sodium channel blocker antiepileptic drugs (AEDs) on the efficacy of adjunctive perampanel for partial-onset seizures: an analysis of pooled Phase III data","volume":"54","author":"Kwan","year":"2013","journal-title":"Epilepsia"},{"issue":"Suppl. s197","key":"10.1016\/j.seizure.2014.06.001_bib0110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/ane.12100","article-title":"Preclinical pharmacology of perampanel, a selective non-competitive AMPA receptor antagonist","volume":"127","author":"Rogawski","year":"2013","journal-title":"Acta Neurol Scand"},{"issue":"Suppl. 1","key":"10.1016\/j.seizure.2014.06.001_bib0115","first-page":"216","article-title":"Population pharmacokinetics and pharmacodynamics of perampanel: a pooled analysis from three phase III trials","volume":"12","author":"Laurenza","year":"2012","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.seizure.2014.06.001_bib0120","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.eplepsyres.2012.10.003","article-title":"Carbamazepine, but not valproate, displays pharmacoresistance in lamotrigine-resistant amygdala kindled rats","volume":"104","author":"Srivastava","year":"2013","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2014.06.001_bib0125","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.eplepsyres.2003.08.003","article-title":"Isobolographic and subthreshold methods in the detection of interactions between oxcarbazepine and conventional antiepileptics \u2013 a comparative study","volume":"56","author":"Luszczki","year":"2003","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2014.06.001_bib0130","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00702-007-0006-3","article-title":"Interactions between tiagabine and conventional antiepileptic drugs in the rat model of complex partial seizures","volume":"115","author":"Borowicz","year":"2008","journal-title":"J Neural Transm"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131114001654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131114001654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:44:05Z","timestamp":1761011045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131114001654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S1059131114001654"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2014.06.001","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacodynamic and pharmacokinetic interactions of perampanel and other antiepileptic drugs in a rat amygdala kindling model","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2014.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}